Clinico-epidemiological profile of SARS-CoV-2 infection in individuals investigated at tertiary care hospital

Sherwani N, Singh N, Verma N, Jain K, Neral A, Gahlot R, Dhurandhar T, Deep H

Pdf Page Numbers :- 187-191

Nikita Sherwani¹, Neha Singh^1,*, Nirmal Verma², Kamlesh Jain², Arvind Neral³, Rupam Gahlot¹, Tripti Dhurandhar², and Harsh Deep²

¹Virology Lab, Department of Microbiology, Pt. JNM Medical College, Raipur, Chhattisgarh-492001, India

²Department of Community Medicine, Pt. JNM Medical College, Raipur, Chhattisgarh-492001, India

³Department of Pathology, Pt. JNM Medical College, Raipur, Chhattisgarh-492001, India

*Corresponding author: Dr. Neha Singh, Virology lab, Department of Microbiology, Pt. JNM Medical College, Raipur, Chhattisgarh-492001, India. Email: nevi0007@gmail.com

Received 18 June 2021; Revised 2 September 2021; Accepted 14 September 2021; Published 22 September 2021

Citation: Sherwani N, Singh N, Verma N, Jain K, Neral A, Gahlot R, Dhurandhar T, Deep H. Clinico-epidemiological profile of SARS-CoV-2 infection in individuals investigated at tertiary care hospital. J Med Sci Res. 2021; 9(4):187-191. DOI: http://dx.doi.org/10.17727/JMSR.2021/9-28

Copyright: © 2021 Sherwani N et al. Published by KIMS Foundation and Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PDF

Abstract

Background: The World Health Organization (WHO) declared the pandemic disease caused by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). Presently, COVID-19 has infected individuals in over seventy nations across the world. China had a significant COVID-19 impact and taken great measures to restrict the disease's development and increase the cure rate.

Objective: Research paper describes the clinico-epidemiological profile of SARS-CoV-2 infection in individuals tested at state key Virology Research and Diagnostic Laboratory (VRDL), Pt. J.N.M. Medical College, Raipur (CG), India.

Method: Respiratory samples oropharyngeal and nasopharyngeal swabs were collected in VTM from suspected COVID-19 individuals for laboratory analysis and cases were confirmed by reverse transcription polymerase chain reaction (RT-PCR). A total of 32,145 patients with confirmed diagnosis of SARS-CoV-2 infection were included in this study. Data included in this study, from the period of August 2020 to February 2021, were collected from offline and online medical records.

Result: Amongst 32,145 SARS-CoV-2 infected patients, 19674 (61%) were males and 12471 (39%) were females, 5756 (17.90%) were symptomatic and 26,389 (82.10%) were asymptomatic. Maximum percentage of symptomatic subjects were found in 70-79 years (25%) followed by 60-69 years (24%), out of 5756 symptomatic patients 3772 (65.53%) were males and 1984 (34.46%) were females, most common presenting symptom was cough (80.9%) followed by fever (33.8%), sore throat (16.1%) breathlessness (14.1%). The most common comorbidity found among symptomatic group was hypertension followed by diabetes.

Conclusion: COVID-19 is an evolving disease and data from our study help in understanding the clinic-epidemiological profile of patients.

Keywords: SARS-CoV-2; clinico-epidemiological; RT-PCR; COVID-19